These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 39055892)
1. Fibroblast activation protein (FAP) as a prognostic biomarker in multiple tumors and its therapeutic potential in head and neck squamous cell carcinoma. Li R; Nan X; Li M; Rahhal O Oncol Res; 2024; 32(8):1323-1334. PubMed ID: 39055892 [TBL] [Abstract][Full Text] [Related]
2. FAP Serves as a Prognostic Biomarker in Head and Neck Squamous Cell Carcinoma. Liao Z; Fan H; Weng J; Zhou J; Zheng Y Anal Cell Pathol (Amst); 2024; 2024():8810804. PubMed ID: 38826849 [TBL] [Abstract][Full Text] [Related]
3. FAP is a prognostic marker, but not a viable therapeutic target for clinical translation in HNSCC. Liu J; Ouyang Y; Xia Z; Mai W; Song H; Zhou F; Shen L; Chen K; Li X; Zhuang SM; Liao J Cell Oncol (Dordr); 2024 Apr; 47(2):623-638. PubMed ID: 37856075 [TBL] [Abstract][Full Text] [Related]
4. FOXD1 is a prognostic biomarker and correlated with macrophages infiltration in head and neck squamous cell carcinoma. Liang H; Zhang C; Li C; Li C; Wang Y; Lin H Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34028536 [TBL] [Abstract][Full Text] [Related]
5. CELSR3 is a prognostic marker in HNSCC and correlates with immune cell infiltration in the tumor microenvironment. Wu Z; Zhu Z; Wu W; Hu S; Cao J; Huang X; Xie Q; Deng C Eur Arch Otorhinolaryngol; 2024 Jun; 281(6):3143-3156. PubMed ID: 38507078 [TBL] [Abstract][Full Text] [Related]
6. TPPP3 Associated with Prognosis and Immune Infiltrates in Head and Neck Squamous Carcinoma. Yang Z; Li X; Li J; Su Q; Qiu Y; Zhang Z; Zhang L; Mo W Biomed Res Int; 2020; 2020():3962146. PubMed ID: 33083464 [TBL] [Abstract][Full Text] [Related]
7. SLC13A4 Might Serve as a Prognostic Biomarker and be Correlated with Immune Infiltration into Head and Neck Squamous Cell Carcinoma. Yang ML; Zhang JH; Li S; Zhu R; Wang L Pathol Oncol Res; 2021; 27():1609967. PubMed ID: 34840533 [TBL] [Abstract][Full Text] [Related]
8. Downregulation of FAP suppresses cell proliferation and metastasis through PTEN/PI3K/AKT and Ras-ERK signaling in oral squamous cell carcinoma. Wang H; Wu Q; Liu Z; Luo X; Fan Y; Liu Y; Zhang Y; Hua S; Fu Q; Zhao M; Chen Y; Fang W; Lv X Cell Death Dis; 2014 Apr; 5(4):e1155. PubMed ID: 24722280 [TBL] [Abstract][Full Text] [Related]
9. Identification of CCT3 as a prognostic factor and correlates with cell survival and invasion of head and neck squamous cell carcinoma. Wang Y; Liu P; Zhang Z; Wang J; Cheng Z; Fan C Biosci Rep; 2021 Oct; 41(10):. PubMed ID: 34505628 [TBL] [Abstract][Full Text] [Related]
10. Investigating the complex interplay between fibroblast activation protein α-positive cancer associated fibroblasts and the tumor microenvironment in the context of cancer immunotherapy. Kraxner A; Braun F; Cheng WY; Yang TO; Pipaliya S; Canamero M; Andersson E; Harring SV; Dziadek S; Bröske AE; Ceppi M; Tanos T; Teichgräber V; Charo J Front Immunol; 2024; 15():1352632. PubMed ID: 39035007 [TBL] [Abstract][Full Text] [Related]
11. FOXD1 expression in head and neck squamous carcinoma: a study based on TCGA, GEO and meta-analysis. Huang J; Liang B; Wang T Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34269372 [TBL] [Abstract][Full Text] [Related]
12. ITGA5 is associated with prognosis marker and immunosuppression in head and neck squamous cell carcinoma. Liu J; Wang Y; Chen X; Chen X; Zhang M Diagn Pathol; 2024 Oct; 19(1):134. PubMed ID: 39375732 [TBL] [Abstract][Full Text] [Related]
13. LPAR2 correlated with different prognosis and immune cell infiltration in head and neck squamous cell carcinoma and kidney renal clear cell carcinoma. Sun K; Chen RX; Li JZ; Luo ZX Hereditas; 2022 Mar; 159(1):16. PubMed ID: 35241179 [TBL] [Abstract][Full Text] [Related]
14. Profiles of immune cell infiltration in head and neck squamous carcinoma. Liang B; Tao Y; Wang T Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32095823 [TBL] [Abstract][Full Text] [Related]
15. Syntenin-1 is a promoter and prognostic marker of head and neck squamous cell carcinoma invasion and metastasis. Cui L; Cheng S; Liu X; Messadi D; Yang Y; Hu S Oncotarget; 2016 Dec; 7(50):82634-82647. PubMed ID: 27811365 [TBL] [Abstract][Full Text] [Related]
16. Signal peptidase complex catalytic subunit SEC11A upregulation is a biomarker of poor prognosis in patients with head and neck squamous cell carcinoma. Hu C; Fan J; He G; Dong C; Zhou S; Zheng Y PLoS One; 2022; 17(6):e0269166. PubMed ID: 35653344 [TBL] [Abstract][Full Text] [Related]
17. Increased Expression of PDGFA Is Associated With Poor Prognosis and Immune Infiltration in Head and Neck Squamous Cell Carcinoma. Wang K; Li C; Chen H; Gu P; Lu J; Zhao H; Zhuo X J Oral Pathol Med; 2024 Oct; 53(9):584-594. PubMed ID: 39295197 [TBL] [Abstract][Full Text] [Related]
18. High expression of ACTL8 is poor prognosis and accelerates cell progression in head and neck squamous cell carcinoma. Li B; Zhu J; Meng L Mol Med Rep; 2019 Feb; 19(2):877-884. PubMed ID: 30535476 [TBL] [Abstract][Full Text] [Related]
19. Comprehensive characterization of the alternative splicing landscape in head and neck squamous cell carcinoma reveals novel events associated with tumorigenesis and the immune microenvironment. Li ZX; Zheng ZQ; Wei ZH; Zhang LL; Li F; Lin L; Liu RQ; Huang XD; Lv JW; Chen FP; He XJ; Guan JL; Kou J; Ma J; Zhou GQ; Sun Y Theranostics; 2019; 9(25):7648-7665. PubMed ID: 31695792 [TBL] [Abstract][Full Text] [Related]
20. Comprehensive analysis of endoplasmic reticulum stress related signature in head and neck squamous carcinoma. Miao Y; Chen Q; Liu X; Bu J; Zhang Z; Liu T; Yue Z; Huang L; Sun S; Li H; Yang A; Yang Z; Chen C Sci Rep; 2024 Jul; 14(1):16972. PubMed ID: 39043683 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]